T-Cell Leukemia Translocation Altered (TCTA) (Middle Region) Peptide
TCTA
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN984927
150,78 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination:
France
Envoi sous 15 à 22 jours ouvrables
Aperçu rapide pour T-Cell Leukemia Translocation Altered (TCTA) (Middle Region) Peptide (ABIN984927)
Antigène
TCTA
(T-Cell Leukemia Translocation Altered (TCTA))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-TCTA antibody (Catalog #: ARP49704_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- TCTA (T-Cell Leukemia Translocation Altered (TCTA))
-
Sujet
-
A chromosomal aberration, translocation t(1,3)(p34,p21), involving TCTA is associated with T-cell acute lymphoblastic leukemia (T-ALL).
Alias Symbols: -
Protein Interaction Partner: SMAD4
Protein Size: 103 -
Poids moléculaire
- 11 kDa
-
ID gène
- 6988
-
NCBI Accession
- NM_022171, NP_071503
-
UniProt
- P57738
Antigène
-
Vous êtes ici:
